Microcarrier Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

Cell culture techniques have become relatively important for the production of many vital biological products such as vaccines, antibodies, enzymes, hormones, and interferons. Microcarriers provide convenient surfaces for growing animal cells, increasing the yield of cells from culture vessels, and perfusion chambers. Several types of microcarriers are available in the microcarrier market, proving beneficial for efficient research and production of biological products. Microcarriers are very useful to grow adherent cell populations in the large-scale commercial production of biologics, biosimilars, and vaccines. Nowadays, biopharmaceutical production requires greater efficiency, fast technologies, low-cost methods, and more flexibility. Microcarriers provide ideal production of biological components, save time, reduce investment costs, and can be used in different production schemes. 
    
The microcarrier market is expected to witness a robust growth in the near future. The market is mainly driven by factors such as ongoing cell-based research, increasing government investments, funds, and grants for research in this field. However, the major market restraints include the need for  high capital investments and limitations in the production of high density cell culture. Moreover, flourishing pharmaceutical industry in Asia Pacific region and growing technological advancements in the microcarriers are expected to offer lucrative growth opportunities for the market in the near future. 

On the basis of product, the global microcarrier market is segmented into equipment and consumables. The equipment segment is further segmented into bioreactors, culture vessels, filtration systems, cell counters, and accessories. The consumables segment is further sub-segmented into reagents, media, and microcarrier beads. Microcarrier beads are further segmented into cationic microcarriers, collagen-coated microcarriers, and other. 

On the basis of the application segment, the microcarrier market is divided into vaccine manufacturing, cell therapy, and other. The vaccine manufacturing segment dominated the application segment due to the greater product demand from the biopharmaceutical sector. The cell therapy segment was the fastest growing segment owing to developments in stem cell therapy and increasing R&D activities to develop new cell-based therapies.

On the basis of the end-user segment, the microcarrier market is divided into pharmaceutical and biotechnology companies, research institutes, and CROs. Among these, pharmaceutical and biotechnology companies segment was the major revenue grossing segment in 2017.

Based on the geography, the global microcarrier market is divided into five regions, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant region in terms of revenue generation followed by Europe. Asia Pacific was the fastest growing market with the highest year on year growth rate. The Middle East and Africa and Latin America are expected to experience slow growth in the microcarrier market in the years to come.  

Some of the key players in microcarrier market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Corning Incorporated, Lonza, Becton, Dickinson and Company, Eppendorf AG, HiMedia Laboratories, and Sartorius AG, among others.